Comparative efficacy and safety of selective serotonin reuptake inhibitors in the short- and medium-term treatment of major depressive disorders

Nordic Journal of Psychiatry

Volumn 50, Issue 1, 1996, Pages 55-59

  Wålinder, Jan ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Efficacy; Selective serotonin reuptake inhibitors; Tolerability; Toxicity

Indexed keywords

AMITRIPTYLINE; CITALOPRAM; DOSULEPIN; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MAPROTILINE; MIANSERIN; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ARTICLE; CARDIOVASCULAR DISEASE; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; HUMAN; NAUSEA; ORTHOSTATIC HYPOTENSION; SEXUAL DYSFUNCTION; VISUAL IMPAIRMENT; WEIGHT GAIN; XEROSTOMIA;

EID: 0030051104     PISSN: 08039496     EISSN: None     Source Type: Journal    
DOI: 10.3109/08039489609081389     Document Type: Article

References (32)

1. Bengtsson B-O. On the hypersensitive syndrome induced by the selective serotonin reuptake inhibiting antidepressant zimelidine. A clinical and experimental study. Linköping University Medical Dissertations 1992, No 360.
2. Feighner JP, Boyer WF. Selective serotonin reuptake inhibitors. In: Perspectives in psychiatry. Vol 1. Chichester: John Wiley Ltd., 1991.
3. Montgomery SA, Montgomery DB. Prophylactic treatment in recurrent unipolar depression. In: Montgomery S, Rouillon F, editors. Long-term treatment of depression. Perspectives in psychiatry. Vol 3. Chichester: John Wiley and Sons, 1992: 53-79.
4. Stark P, Hardison C. A review of multicenter controlled studies of fluoxetine vs imipramine and placebo in outpatients with major depressive disorder. J Clin Psychiatry 1985;46:3:53-8.
5. Dunner DL, Dubar GC. Optimal dose regimen for paroxetine. J Clin Psychiatry 1992;53 Suppl 2:21-6.
6. Montgomery SA, Pedersen V, Tanghøj P, Rasmussen C. The optimal dosing regimen for citalopram - a meta-analysis of nine placebo-controlled studies. Int Clin Psychopharmacol 1994;9 Suppl 1:35-40.
7. Grimsley SR, Jann MW. Paroxetine, sertraline and fluvoxamine: new selective serotonin reuptake inhibitors. Clin Pharmacol 1992;11:930-57.
8. Aguglia E, Casacchia M, Casano GB, Faravelli C, et al. Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression. Int Clin Psychopharmacol 1993;8:197-202.
9. Schöne W, Ludwig M. A double-blind study of paroxetine compared with fluoxetine in geriatric patients with major depression. J Clin Psychopharmacol 1993;13 Suppl 2:34S-39S.
10. Tignol J. A double-blind, randomized fluoxetine-controlled, multicenter study of paroxetine in the treatment of depression. J Clin Psychopharmacol 1993;13 Suppl 2:18S-22S.
11. De Wilde J, Spiers R, Mertens C, Bartholome F, Schott E, Leyman S. A double-blind, comparative, multicentre study comparing paroxetine with fluoxetine in depressed patients. Acta Psychiatr Scand 1993;87:141-5.
12. Geretsegger C, Böhmer F, Ludwig M. Paroxetine in the elderly depressed patient: randomized comparison with fluoxetine of efficacy, cognitive and behavioural effects. Int Clin Psychopharmacol 1994;9:25-9.
13. Timmerman L, Haffmans PMJ, Hoogduin CAL. Efficacy and tolerability of citalopram in comparison with fluvoxamine in depressed outpatients. J Clin Psychopharmacol. In press.
14. Ansseau M. A double-blind comparison of paroxetine and fluvoxamine in major depression. Eur Neuropsychopharmacol 1993;3:232-4.
15. Wålinder J, Feighner JP. Novel selective serotonin reuptake inhibitions. I. J Clin Psychiatry 1992;53: 107-12.
16. Brown WA, Harrison W. Are patients who are intolerant to one SSRI intolerant to another? Psychopharmacol Bull 1992;28:253-6.
17. Goodwin FK, Jamison KR. Manic-depressive illness. New York: Oxford University Press, 1990.
18. Bjerkenstedt L, Edman G, Flyckt L, Hagenfelt L, Sedvall G, Wiesel FA. Clinical and biochemical effects of citalopram, a selective 5-HT reuptake inhibitor - a dose response study in depressed patients. Psychopharmacology 1985;887:253-9.
19. Sternbach H. The serotonin syndrome. Am J Psychiatry 1991;148:705-13.
20. Edwards JG, Goldie A, Papayanni-Papasthasis S, Punter J, Sedgwick EM. The effect of paroxetine on the electroencephalogram, electrocardiogram and blood pressure. Acta Psychiatr Scand 1989;80 Suppl 350:124.
21. Rasmussen JGC, Johnson AM. Incidence of seizures during treatment with antidepressants, including the serotonin re-uptake inhibitor paroxetine. Poster presented at the 5th World Congress of Psychiatry, Florence, June 9-14, 1991.
22. Riddle MA, Brown N, Dzubinski D, Jetmalani AN, Law Y, Woolston JL. Fluoxetine overdose in an adolescent. J Am Acad Child Adolesc Psychiatry 1989;28:587-8.
23. Ware MR, Stewart RB. Seizures associated with fluoxetine therapy. Drug Intell Clin Pharm 1989; 23:428.
24. Weber JJ. Seizures activity associated with fluoxetine therapy. Clin Pharmacol 1989;8:296-8.
25. Andersen G, Vestergaard K, Riis Jens O. Citalopram for post-stroke pathological crying. Lancet 1993;342:837-9.
26. Andersen G, Vestergaard K, Lauritzen L. Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 1994;25:1099-104.
27. Nyth AL, Gottfries CG. The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre study. Br J Psychiatry 1990;157:894-901.
28. Rasmussen JGC, Manniche P. Incidence of mania during treatment with antidepressants, with particular reference to the selective serotonin re-uptake inhibitor paroxetine. Poster presented at the 5th World Congress of Psychiatry, Florence, June 9-14, 1991.
29. Mårtensson B. Åberg-Wistedt A. Selektiva hämmare av serotoninupptag. Ny grupp antidepressiva medel ökar i användning. Lakartidningen 1994;38:3371-9.
30. Molcho A, Stanley M. Antidepressants and suicide risk: issues of chemical and behavioural toxicity. J Clin Psychopharmacol 1992;12:13-8.
31. Leonard BE. The comparative pharmacology of new antidepressants. J Clin Psychiatry 1993; 54:3-15.
32. Eriksson T, Carlsson A, Eriksson TE, Wålinder J. Altered night plasma concentrations of tryptophan and tyrosine in mental depression. J Neural Transmission. In press.